Lyra Therapeutics pockets $30 mln Series C

Watertown, Massachusetts-based Lyra Therapeutics Inc, a developer of medicines to treat ear, nose and throat diseases, has raised $30 million in Series C financing.

Watertown, Massachusetts-based Lyra Therapeutics Inc, a developer of medicines to treat ear, nose and throat diseases, has raised $30 million in Series C financing. Perceptive Advisors led the round with participation from other investors that included Clifton Capital, RA Capital Management, Soleus Capital, ArrowMark Partners, Polaris Venture Partners, North Bridge Venture Partners and Intersouth Partners.

Source: Press Release